Skip to main content

Advertisement

Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus

Fig. 2

The distribution of the proportions of patients with high levels of each IFN measurement. The Venn diagram depicts how patient groups with high levels of different IFNs distribute and overlap in the cohort (a), and among those with active SLE as scored by SLAM (b) and SLEDAI (c). Only patients in whom all four measurements were available are included in the analysis (n = 248). The number outside diagram indicates the number of patients who had none of the IFNs expressed at a high level (> 75th percentile of patient measures)

Back to article page